Clinical Research Directory
Browse clinical research sites, groups, and studies.
Adjunct Episcleral Brachytherapy for PCV
Sponsor: Salutaris Medical Devices, Inc.
Summary
This study is investigating the use of episcleral brachytherapy (ESB) adjunct to aflibercept compared to aflibercept monotherapy for the treatment of polyploid choroidal vasculopathy (PCV) in patients experiencing an inadequate response to anti-VEGF monotherapy.
Official title: A Double-Masked, Multi-center, Active Controlled Safety and Efficacy Study of Adjunct Episcleral Brachytherapy for Polypoid Choroidal Vasculopathy
Key Details
Gender
All
Age Range
50 Years - Any
Study Type
INTERVENTIONAL
Enrollment
159
Start Date
2025-03
Completion Date
2028-09
Last Updated
2023-08-30
Healthy Volunteers
No
Interventions
Episcleral Brachytherapy
Minimally invasive, single fraction brachytherapy
Aflibercept Injection
Standard of Care intravitreal aflibercept injection